BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi Y, Zheng H, Wang M, Ding S. Influence of Helicobacter pylori infection on PD-1/PD-L1 blockade therapy needs more attention. Helicobacter 2022;:e12878. [PMID: 35112435 DOI: 10.1111/hel.12878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng R, Zheng H, Cai H, Li M, Shi Y, Ding S. Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses. Front Immunol 2022;13:923477. [DOI: 10.3389/fimmu.2022.923477] [Reference Citation Analysis]
2 Oster P, Vaillant L, Mcmillan B, Velin D. The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection. Front Immunol 2022;13:899161. [DOI: 10.3389/fimmu.2022.899161] [Reference Citation Analysis]